Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
17.36
+0.70 (4.20%)
At close: Oct 15, 2025, 4:00 PM EDT
17.45
+0.09 (0.52%)
After-hours: Oct 15, 2025, 7:57 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.84 billion as of October 15, 2025. Its market cap has decreased by -61.13% in one year.
Market Cap
1.84B
Enterprise Value
1.47B
1-Year Change
-61.13%
Ranking
Category
Stock Price
$17.36
Market Cap Chart
Since October 18, 2022, Biohaven's market cap has increased from $412.66M to $1.84B, an increase of 345.05%. That is a compound annual growth rate of 64.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.84B | -51.37% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 129.26% |
| Oct 18, 2022 | 412.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |